PEP-1324: Glycemic Response Testing
Not Applicable
- Conditions
- Glycemic Response
- Interventions
- Other: Nutrient formulation
- Registration Number
- NCT02037854
- Lead Sponsor
- PepsiCo Global R&D
- Brief Summary
The purpose of this study is to assess whether food ingredient(s) affect glycemic and insulinemic responses.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Subject is 18-75 years of age
- Subject is male or non-pregnant females, 18-75 years of age, inclusive
- Subject has a body mass index (BMI) ≥ 20.0 and < 35 kg/m² at screening (visit 1).
- Subject has to be non-smoker.
- Subject is willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
- Subject is willing to maintain current dietary supplement use throughout the trial. On test days, subject agrees not to take any dietary supplements until dismissal from the GI labs. Failure to comply will result in a rescheduled test visit.
- Subject has normal fasting serum glucose (<7.0mmol/L capillary corresponding to whole blood glucose <6.3mmol/L).
- Subject is willing to abstain from alcohol consumption and avoid vigorous physical activity for 24 h prior to all test visits.
- Subject has no health conditions that would prevent him from fulfilling the study requirements as judged by the Investigator on the basis of medical history.
- Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study investigator.
Exclusion Criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Nutrient formulation Nutrient formulation Nutrient formulations with variable amounts of active ingredients. Placebo Nutrient formulation A nutrient formulation without the active ingredient
- Primary Outcome Measures
Name Time Method Incremental area under the blood glucose response cruve 0-2 hours
- Secondary Outcome Measures
Name Time Method peak insulin 0-2 hours peak blood glucose 0-2 hours
Trial Locations
- Locations (1)
GI Labs
🇨🇦Toronto, Ontario, Canada